Brief: Galmed Pharmaceuticals Announces Receipt Of Extension To Meet The Nasdaq's Minimum Bid Price Requirement

Eocene

14/12/2022 22:21

Dec 14 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS LTD. (NASDAQ: GLMD) ANNOUNCES
RECEIPT OF
EXTENSION TO MEET THE NASDAQ'S MINIMUM BID PRICE REQUIREMENT

Source text for Eikon:  ID:nPn6Wr5zma 
Further company coverage:  GLMD.O 
 ((Reuters.Briefs@thomsonreuters.com;;))